Hydroquinone analog 4-[(Tetrahydro-2H-pyran-2‑yl) oxy] phenol induces C26 colon cancer cell apoptosis and inhibits tumor growth in vivo

Du,Qigen; Xin,Guang; Niu,Hai; Huang,Wen

doi:10.3892/mmr.2015.3300

Hydroquinone analog 4-[(Tetrahydro-2H-pyran-2‑yl) oxy] phenol induces C26 colon cancer cell apoptosis and inhibits tumor growth in vivo

Authors:
- Qigen Du
- Guang Xin
- Hai Niu
- Wen Huang
View Affiliations

Affiliations: Laboratory of Ethnopharmacology, Regenerative Medicine Research Center, West China Hospital, West China Medical School and Institute for Nanobiomedical Technology and Membrane Biology, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: February 4, 2015 https://doi.org/10.3892/mmr.2015.3300
Pages: 4671-4677

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The 4[(Tetrahydro‑2H‑pyran‑2‑yl) oxy] phenol (XG‑d) hydroquinone analog, is found in Vaccinium vitis‑idaea L. Although it is known for its antioxidant properties and high level of safety, its antitumor activity remains to be elucidated. In the present study, the anticancer effect of XG‑d was determined in vitro and in vivo. The cytotoxicity of XG‑d against C26 murine colon carcinoma cells was found to occur in a time‑ and concentration‑dependent manner, whereas little effect was observed in the two normal cell lines (HK‑2 and L02) investigated. Oral administration of XG‑d (100 mg/kg) had effects on the tumor growth of tumor‑bearing mice. Furthermore, marked apoptosis was observed using Hoechst 33258 staining and flow cytometric analysis with annexin V/propidium iodide double staining. XG‑d also downregulated the expression of B‑cell lymphoma 2 (Bcl‑2), increased the expression levels of Bcl‑2‑associated X protein and activated caspase‑9, caspase‑3 and poly(adenosine diphosphate‑ribose) polymerase. The present study demonstrated for the first time, to the best of our knowledge, that XG‑d inhibited cancer cell growth via the induction of apoptosis and was also able to inhibit tumor growth in vivo. These results demonstrated that XG‑d may be used as a potential natural agent for cancer therapy with low toxicity.

View Figures

View References

1	Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar : PubMed/NCBI
2	Center MM, Jemal A, Smith RA and Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin. 59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
3	Jemal A, Bary F, Center MM, et al: Global cancer statistic. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
4	Saif MW: Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Canc. 6:46–51. 2006. View Article : Google Scholar
5	Macdonald JS: Adjuvant therapy of colon cancer. CA Cancer J Clin. 49:202–219. 1999. View Article : Google Scholar
6	Longley DB, Harkin DP and Johnston PG: 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 3:330–338. 2003. View Article : Google Scholar : PubMed/NCBI
7	Delval L and Klastersky J: Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature. J Neurooncol. 60:165–169. 2002. View Article : Google Scholar
8	Meregalli M, Martignoni G, Frontini L, et al: Increasing doses of 5-fluorouracil and high-dose folinic acid in the treatment of metastatic colorectal cancer. Tumori. 84:662–665. 1998.
9	Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
10	Ziegler DS and Kung AL: Therapeutic targeting of apoptosis pathways in cancer. Curr Opin Oncol. 20:97–103. 2008. View Article : Google Scholar
11	Wong RSY: Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI
12	Green DR and Kroemer G: The pathophysiology of mitochondrial cell death. Science. 305:626–629. 2004. View Article : Google Scholar : PubMed/NCBI
13	Borner C: The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol. 39:615–647. 2003. View Article : Google Scholar
14	Adams JM and Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 26:1324–1337. 2007. View Article : Google Scholar : PubMed/NCBI
15	Willis SN, Fletcher J, Kaufmann T, et al: Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 315:856–859. 2007. View Article : Google Scholar : PubMed/NCBI
16	Tin MM, Cho CH, Chan K, et al: Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis. 28:1347–1355. 2007. View Article : Google Scholar
17	Miller K, Wang ML, Gralow J, et al: Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. New Engl J Med. 357:2666–2676. 2007. View Article : Google Scholar : PubMed/NCBI
18	Phillips PA, Sangwan V, Borja-Cacho D, et al: Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Lett. 308:181–188. 2011. View Article : Google Scholar : PubMed/NCBI
19	Morimoto S, Nonaka GI and Nishioka I: Tannins and related compounds. LX. Isolation and characterization of proanthocy-anidins with a doubly-linked unit from Vaccinium vitis-idaea L. Chem Pharm Bull. 36:33–38. 1988. View Article : Google Scholar
20	Fokina GI, Roĭkhel’ VM, Frolova MP, et al: The antiviral action of medicinal plant extracts in experimental tick-borne encephalitis. Vopr Virusol. 38:170–173. 1993.In Russian. PubMed/NCBI
21	Tong QY, Qing Y, Shu D, et al: Deltonin, a steroidal saponin, inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis and antiangiogenesis. Cell Physiol Biochem. 27:233–242. 2011. View Article : Google Scholar : PubMed/NCBI
22	Jeone SJ, Koh W, Kim B and Kim SH: Are there new therapeutic options for treating lung cancer based on herbal medicines and their metabolites. J Ethnopharmacology. 138:652–661. 2011. View Article : Google Scholar
23	Wang J, Zhao XZ, Qi Q, et al: Macranthoside B, a hederagenin saponin extracted from Lonicera macranthoides and its anti-tumor activities in vitro and in vivo. Food Chem Toxicol. 47:1716–1721. 2009. View Article : Google Scholar : PubMed/NCBI
24	Hu M, Xu L, Yin LH, et al: Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J Appl Toxicol. 33:712–722. 2013. View Article : Google Scholar
25	Cai SX, Drewe J and Kasibhatla S: A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets. Curr Med Chem. 13:2627–2644. 2006. View Article : Google Scholar : PubMed/NCBI
26	Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:121–139. 1992. View Article : Google Scholar : PubMed/NCBI
27	Desagher S and Martinous JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
28	Gabriel B, Sureau F, Casselyn M, et al: Retroactive pathway involving mitochondria in electroloaded cytochrome c-induced apoptosis. Protective properties of Bcl-2 and Bcl-XL. Exp Cell Res. 289:195–210. 2003. View Article : Google Scholar : PubMed/NCBI
29	Maianski NA, Roos D and Kuijpers TW: Bid truncation, bid/bax targeting to the mitochondria, and caspase activation associated with neutrophil apoptosis are inhibited by granulocyte colony-stimulating factor. J Immunol. 172:7024–7030. 2004. View Article : Google Scholar : PubMed/NCBI
30	Nuñez G, Benedict MA, Hu Y and Inohara N: Caspases: the proteases of the apoptotic pathway. Oncogene. 17:3237–3245. 1998. View Article : Google Scholar
31	Duriez PJ and Shah G: Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol. 75:337–349. 1997. View Article : Google Scholar : PubMed/NCBI
32	Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2:647–656. 2002. View Article : Google Scholar : PubMed/NCBI
33	Oltersdorf T, Elmore SW, Shoemaker AR, et al: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 435:677–681. 2005. View Article : Google Scholar : PubMed/NCBI
34	Murray A: Cyclin ubiquitination: the destructive end of mitosis. Cell. 81:149–152. 1995. View Article : Google Scholar : PubMed/NCBI
35	Antonsson B and Martinou JC: The Bcl-2 protein family. Exp Cell Res. 256:50–57. 2000. View Article : Google Scholar : PubMed/NCBI
36	Reed JC: Double identity for protein of the Bcl-2 family. Nature. 387:773–776. 1997. View Article : Google Scholar : PubMed/NCBI
37	Mirjolet JF, Barberi-Heyob M, Didelot C, et al: Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Br J Cancer. 83:1380–1386. 2000. View Article : Google Scholar : PubMed/NCBI